Role of Specialty Pharmacists in Preventing Vision Loss Resulting from Macular Edema

Specialty Pharmacy Times, May/June 2016, Volume 7, Issue 3

Role of Specialty Pharmacists in Preventing Vision Loss Resulting from Macular Edema

FACULTY

Eva Y. Wong, PharmD, BCPS, BCACP, CDE

Department of Pharmacy Practice

College of Pharmacy

Marshall B. Ketchum University

Fullerton, California

Robert Yacoub, OD

Diplomate, American Board of Optometry

Board Certified in Medical Optometry

Marshall B. Ketchum University

Fullerton, California

Jack J. Chen, PharmD, BCPS, CGP, FASCP, FCCP

Department of Pharmacy Practice

College of Pharmacy

Marshall B. Ketchum University

Fullerton, California

DISCLOSURES

The following contributor(s) have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education Planning Staff

David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Tara DeLorenzo

Specialty Pharmacy Times Editorial Staff—Davy James

An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

1. Demonstrate knowledge of the risk factors, pathophysiology, and etiology of diabetic macular edema.

2. Examine the mechanism of action and safety and efficacy profile of the different treatment classes and individual agents available for the management of diabetic macular edema.

3. Illustrate the need for pharmacists to educate patients on the importance of routine eye examination and early detection in preventing loss of vision.

Target audience: Specialty Pharmacists

Activity Type: Application

Release date: June 12, 2016

Expiration date: June 12, 2017

Estimated time to complete activity: 2.0 hours

Fee: This lesson is offered for free at www.pharmacytimes.org.

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-16-067-H01-P. The activity is available for CE credit through June 12, 2017.